Announcements Trials
Browse Landscape

Status

Withdrawn 1Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Uveal Neoplasms 1Uveal Melanoma 1Thyroid Neoplasms 1Sarcoma, Ewing 1Neoplasm Metastasis 1Melanoma 1Iris Neoplasms 1Choroid Neoplasms 1Breast Neoplasms 1

Interventions

Nivolumab 17Ipilimumab 14pembrolizumab 11Cyclophosphamide 8trametinib 7dabrafenib 6Interleukin-2 6aldesleukin 5Vemurafenib 5Radiotherapy 5sargramostim 4130-nm albumin-bound paclitaxel 4fludarabine 3encorafenib 3binimetinib 3Specimen Handling 3Radiosurgery 3Melphalan 3Granulocyte-Macrophage Colony-Stimulating Factor 3fludarabine phosphate 2Magnetic Resonance Spectroscopy 2Introns 2Infliximab 2Celecoxib 2CTLA-4 Antigen 2Biopsy 2Bevacizumab 2Albumin-Bound Paclitaxel 2yeast-CEA vaccine 1vitespin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Melanoma × Biopsy, Fine-Needle × Clear all
NCT00406120 2018-06-26

Validation of a Molecular Prognostic Test for Eye Melanoma

Washington University School of Medicine

Withdrawn
Dermatologic

Uveal Melanoma, Choroid Neoplasms, Melanoma, Neoplasm Metastasis, Uveal Neoplasms, Iris Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡